Your browser doesn't support javascript.
loading
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Zheng, Guoxu; Guo, Zhangyan; Li, Weimiao; Xi, Wenjin; Zuo, Baile; Zhang, Rui; Wen, Weihong; Yang, An-Gang; Jia, Lintao.
Afiliação
  • Zheng G; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Guo Z; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Li W; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Xi W; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Zuo B; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Zhang R; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Wen W; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China.
  • Yang AG; State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, Xi'an, China. agyang@fmmu.edu.cn.
  • Jia L; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China. jialth@fmmu.edu.cn.
Signal Transduct Target Ther ; 6(1): 236, 2021 06 23.
Article em En | MEDLINE | ID: mdl-34158475

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Receptores KIR2DL4 / Antígenos HLA-G / Trastuzumab Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Receptores KIR2DL4 / Antígenos HLA-G / Trastuzumab Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido